全球疫苗接种设备市场行业概况及 2031 年预测 - 市场分析和市场份额

全球疫苗接种设备市场 - 行业概况

全球疫苗接种设备市场正在迅速扩张，这得益于全球日益重视免疫接种作为公共卫生的重要组成部分。根据世卫组织的数据，全球女孩第一剂 HPV 疫苗的覆盖率从 2022 年的 20% 增加到 2023 年的 27%。这一增长主要归功于持续开展针对各种传染病的疫苗接种计划，包括流感、COVID-19 和其他地方性疾病。疫苗接种技术的技术改进，例如无针和自接种设备，正在提高疫苗接种效率和舒适度，从而促进市场增长。

Data Bridge 市场研究市场报告提供了最新发展、市场份额、基于细分和区域分析的市场趋势、市场参与者的影响、新兴收入领域机会分析、市场法规变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地理扩展、市场技术创新的详细信息。要获取有关市场的更多信息，请联系 Data Bridge 市场研究的专家分析师团队。我们的团队将帮助您做出明智的市场决策，以实现业务增长。

全球疫苗接种设备市场规模和市场分析

Enhanced public health campaigns are critical in increasing vaccination uptake and combatting vaccine hesitancy, and they play an important role in the expansion of the vaccine administration devices industry.  For instance, the "It's On Us" campaign, which was established during the COVID-19 pandemic, effectively addressed vaccine safety concerns and encouraged inoculation through social media, public service announcements, and community involvement. By effectively addressing vaccination reluctance and misinformation, such initiatives help to boost immunization coverage, thus generating demand for effective vaccine administration devices. As a result, Databridge Market Research dived into comprehensively analyzing the market and unveiled that the Global Vaccine Administration Devices Market is increasing at a CAGR of 7.90%. Our detailed analysis forecasts that the market is valued at USD 3.9 billion in 2023 and is expected to grow upto USD 6.9 billion by 2031. Our meticulously created report, developed through comprehensive research and analytics, is a distinguished paper that unveils eye-opening data about the market.

Global Vaccine Administration Devices Market Dynamics

Global Vaccine Administration Devices Market Growth Drivers

Increased Alliance and immunization programs

The market is driven by increasing immunization programs, rapid increase in immunization initiatives and campaigns, and rising disease rates around the world. For instance, the GAVI Alliance and the Bill & Melinda Gates Foundation are actively participating in immunological campaigns, which should considerably boost the market for vaccination administration devices.

Rise in chronic diseases

The rise in chronic diseases, such as diabetes and heart disease, has led to greater awareness of the importance of vaccination in at-risk populations. The World Health Organization (WHO) estimates that NCDs kill 41 million people each year, which is 74% of all deaths globally. The main types of NCDs are cardiovascular diseases, cancers, chronic respiratory diseases, and diabetes. Patients with chronic conditions often require vaccines that prevent complications from diseases, driving the need for reliable and easy-to-use vaccine administration devices.

Global Vaccine Administration Devices Market Growth Opportunities

Expansion in Emerging Markets

Expansion in emerging markets is significantly impacting the vaccine administration devices sector, driven by the growing healthcare infrastructure and vaccination programs. For instance, India administered over 2 billion doses of vaccines in mid-2022. As Developing regions enhance their healthcare systems and vaccination efforts, there is a rising demand for innovative administration devices to manage the increased vaccine distribution.

Innovation delivering progressive technologies

The vaccine administration devices market is undergoing considerable transformation due to technological breakthroughs such as needle-free injectors and auto-disable syringes. For instance, the Biojector 2000, a needle-free injector, has been successfully utilized in vaccination campaigns for diseases such as influenza and measles, providing a painless alternative that lowers the chance of needle-stick injuries. Such developments not only increase the safety and efficiency of vaccine delivery, but also address major public health concerns, making them critical for the Global Vaccine Administration Devices Market growth.

Global Vaccine Administration Devices Market Growth Challenges

Environmental concerns

The disposal of single-use vaccine administration devices, such as syringes and vials, adds to medical waste and poses environmental and public health risks. According to the World Health Organization (WHO), around 16 billion injections are provided globally each year. The need for sustainable solutions continues to rise, but providing eco-friendly alternatives without sacrificing safety or increasing costs is a challenge for manufacturers. Consequently hampering Global Vaccine Administration Devices Market Growth. 

Differing prices

The high expense of sophisticated vaccine delivery technologies, such as needle-free injectors and auto-disable syringes, poses a unique barrier to their general adoption, particularly in low- and middle-income countries. For instance, needle-free injectors such as PharmaJet's Tropis witness drastic price variation which makes them difficult to afford for large-scale vaccination campaigns in areas with limited healthcare resources.

Global Vaccine Administration Devices Market Growth Restraints

Regulatory hurdles

Regulatory challenges have a substantial impact on the worldwide vaccine administration devices market, as they provide barriers to the timely approval and launch of new technologies. For instance, Indian Central Drugs Standard Control Organization (CDSCO) demands extensive data and local testing before issuing approval, which adds time and cost for firms looking to access this large market.

Global Vaccine Administration Devices Market Scope and Trends

• Innovations Such as 3M’s Smart Syringe incorporate electronic components to track and record injection data, such as dose administration and timing. This technology aims to improve the accuracy of vaccine delivery and enhance patient safety.
• The ICMR and Panacea Biotec have launched India's first phase three clinical trial to produce a dengue vaccine. Panacea Biotec produced DengiAll, India's indigenous tetravalent dengue vaccine, and the first trial participant was vaccinated at the Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences in Rohtak.
• Iran received a substantial shipment of 564,000 doses of Pneumococcal Conjugate Vaccine (PCV), supported by UNICEF. This significant delivery is part of a broader initiative to enhance the country's immunization efforts and improve public health outcomes.
• Vietnam's routine immunization program received a significant boost with the arrival of 490,600 doses of the DTP-HepB-Hib vaccine, provided by Australia in partnership with UNICEF. This crucial shipment supports Vietnam's ongoing efforts to enhance its vaccination coverage and protect children against a range of preventable diseases.

Global Vaccine Administration Devices Market Regional Analysis – Market Trends

Key Insights

• North America's substantial investment in vaccine R&D and public health initiatives supports market expansion. The U.S. and Canada, is a leading market for vaccine administration devices, driven by high healthcare expenditure and advanced medical infrastructure.
• 在欧洲，疫苗接种设备市场规模庞大，得益于完善的医疗保健系统和支持性监管框架。欧盟和英国是主要参与者，重点是采用智能和自动化设备来提高效率和安全性。
• 亚太地区的疫苗注射设备市场正在快速增长，这得益于中国、印度和日本等国家不断扩大的医疗基础设施和大规模疫苗接种计划。由于广泛的公共卫生计划，包括自动失效注射器和无针注射器在内的先进设备的采用正在增加。
• 中东和非洲地区正在逐步采用传统和创新的疫苗接种系统，以加强医疗保健并扩大免疫覆盖率。

全球疫苗接种设备市场领先企业

• BD（美国）
• INOVIO Pharmaceuticals（美国）
• Vaxxas（美国）
• Gerresheimer AG（德国）
• Corium Inc.（美国）
• Enesi（美国）
• Micropoint Technologies（新加坡）
• 肖特股份公司（德国）
• 3M（美国）
• Mystic Pharmaceuticals（美国）
• NanoPass Rev（美国）
• Terumo Europe NV（比利时）
• D'Antonio Consultants International, Inc.（美国）
• West Pharmaceutical Services, Inc.（美国）
• Mylan NV（美国）
• 医疗国际技术公司（加拿大）
• Antares Pharma（美国）

全球疫苗接种设备市场最新发展

• 2023 年 12 月，美国 FDA 因担心其给药机制而暂时搁置了 Inovio 拟议的 DNA 癌症疫苗 VGX-3100 的 III 期研究。美国食品药品管理局 (FDA) 要求提供证据来证实用于给药 VGX-3100 的 Cellectra 5pSp 设备的一次性部件的保质期。
• 2023年11月，联合国儿童基金会和全球疫苗免疫联盟向乌兹别克斯坦卫生部提供价值320万美元的IT和废物管理设备，以帮助推动乌兹别克斯坦的免疫接种计划。
• 2022年3月，根据与联合国儿童基金会达成的紧急协议，日本政府向赞比亚提供了冷链设备，以增强其长期卫生系统能力，包括分发救命的新冠疫苗。
• 2023 年 11 月，Vaxxas 宣布并公布使用其专有的高密度微阵列皮肤贴片进行的麻疹和风疹疫苗 I 期临床试验成功；计划在非洲冈比亚进行 I/II 期试验。

SKU-55561